Detailed answers about CODA HEALTH INNOVATION & REACH LTD, including incorporation, status, business activity, and accounts information.
When was CODA HEALTH INNOVATION & REACH LTD founded?
CODA HEALTH INNOVATION & REACH LTD was officially incorporated on 18 May 2026 and is registered under company number 17226274. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CODA HEALTH INNOVATION & REACH LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CODA HEALTH INNOVATION & REACH LTD?
CODA HEALTH INNOVATION & REACH LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CODA HEALTH INNOVATION & REACH LTD do?
CODA HEALTH INNOVATION & REACH LTD operates in the following sectors: 59112 - Video production activities, 62012 - Business and domestic software development, 63990 - Other information service activities n.e.c., 73120 - Media representation services. These SIC codes provide insight into the company's business activities and industry focus.
What is CODA HEALTH INNOVATION & REACH LTD's registered address?
The registered office address of CODA HEALTH INNOVATION & REACH LTD is 20 Wenlock Road, London, England, N1 7GU. This is the official address filed with Companies House for legal and statutory correspondence.
Is CODA HEALTH INNOVATION & REACH LTD financially stable?
Financial accounts for CODA HEALTH INNOVATION & REACH LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.